216 related articles for article (PubMed ID: 9305871)
1. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines.
Burdick MD; Harris A; Reid CJ; Iwamura T; Hollingsworth MA
J Biol Chem; 1997 Sep; 272(39):24198-202. PubMed ID: 9305871
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.
Zhang K; Baeckström D; Brevinge H; Hansson GC
Tumour Biol; 1997; 18(3):175-87. PubMed ID: 9143414
[TBL] [Abstract][Full Text] [Related]
4. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
6. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
[TBL] [Abstract][Full Text] [Related]
7. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
8. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
9. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
[TBL] [Abstract][Full Text] [Related]
10. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
12. CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines.
Reid CJ; Burdick MD; Hollingsworth MA; Harris A
Glycobiology; 1999 Apr; 9(4):389-98. PubMed ID: 10089213
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.
Magarian-Blander J; Hughey RP; Kinlough C; Poland PA; Finn OJ
Glycoconj J; 1996 Oct; 13(5):749-56. PubMed ID: 8910002
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
19. In vivo glycosylation of MUC1 in airway epithelial cells.
Silverman HS; Sutton-Smith M; Heal P; Parry S; Palmai-Pallag T; Leir SH; Morris HR; Dell A; Harris A
Glycoconj J; 2002 Jul; 19(6):379-84. PubMed ID: 14707484
[TBL] [Abstract][Full Text] [Related]
20. MUC1 and cancer.
Taylor-Papadimitriou J; Burchell J; Miles DW; Dalziel M
Biochim Biophys Acta; 1999 Oct; 1455(2-3):301-13. PubMed ID: 10571020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]